Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,871,761
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1,295,952
-
Shares change
-
+81,556
-
Total reported value, excl. options
-
$5,184,000
-
Value change
-
+$330,313
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$4
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q3 2019
13 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q3 2019.
Anixa Biosciences Inc - Common Stock (ANIX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,295,952 shares
of 37,871,761 outstanding shares and own 3.42% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (668,873 shares), UBS Group AG (261,043 shares), GEODE CAPITAL MANAGEMENT, LLC (102,487 shares), BlackRock Inc. (85,989 shares), NORTHERN TRUST CORP (55,993 shares), Bank of New York Mellon Corp (39,758 shares), JPMORGAN CHASE & CO (36,716 shares), SEGALL BRYANT & HAMILL, LLC (17,400 shares), MORGAN STANLEY (13,212 shares), and RAYMOND JAMES & ASSOCIATES (10,040 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.